SK60895A3 - Taxane derivatives and process for their preparation - Google Patents

Taxane derivatives and process for their preparation

Info

Publication number
SK60895A3
SK60895A3 SK608-95A SK60895A SK60895A3 SK 60895 A3 SK60895 A3 SK 60895A3 SK 60895 A SK60895 A SK 60895A SK 60895 A3 SK60895 A3 SK 60895A3
Authority
SK
Slovakia
Prior art keywords
preparation
taxane derivatives
taxane
derivatives
Prior art date
Application number
SK608-95A
Other languages
Slovak (sk)
Inventor
Jean-Dominique Bourzat
Alain Commercon
Dominique Deprez
Jean-Pierre Pulicani
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of SK60895A3 publication Critical patent/SK60895A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/20—Processes
    • C25B3/25—Reduction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B11/00—Electrodes; Manufacture thereof not otherwise provided for
    • C25B11/04—Electrodes; Manufacture thereof not otherwise provided for characterised by the material
    • C25B11/042—Electrodes formed of a single material
    • C25B11/046—Alloys
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B9/00—Cells or assemblies of cells; Constructional parts of cells; Assemblies of constructional parts, e.g. electrode-diaphragm assemblies; Process-related cell features
    • C25B9/17—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof
    • C25B9/19—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms
    • C25B9/23—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms comprising ion-exchange membranes in or on which electrode material is embedded
SK608-95A 1992-11-12 1993-11-10 Taxane derivatives and process for their preparation SK60895A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9213586A FR2697841B1 (en) 1992-11-12 1992-11-12 New taxane derivatives, their preparation and the pharmaceutical compositions containing them.
PCT/FR1993/001102 WO1994011547A1 (en) 1992-11-12 1993-11-10 Process for the preparation of taxane derivatives, novel taxanes so obtained and antitumour and antileukaemia compositions containing same

Publications (1)

Publication Number Publication Date
SK60895A3 true SK60895A3 (en) 1996-03-06

Family

ID=9435452

Family Applications (1)

Application Number Title Priority Date Filing Date
SK608-95A SK60895A3 (en) 1992-11-12 1993-11-10 Taxane derivatives and process for their preparation

Country Status (15)

Country Link
EP (1) EP0667922A1 (en)
JP (1) JPH08503261A (en)
KR (1) KR950704540A (en)
AU (1) AU5425794A (en)
CA (1) CA2149240A1 (en)
CZ (1) CZ122495A3 (en)
FI (1) FI952294A0 (en)
FR (1) FR2697841B1 (en)
MX (1) MX9306883A (en)
NO (1) NO951772L (en)
PL (1) PL308957A1 (en)
RU (1) RU95112464A (en)
SK (1) SK60895A3 (en)
WO (1) WO1994011547A1 (en)
ZA (1) ZA938366B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
FR2710642B1 (en) * 1993-09-29 1995-11-17 Rhone Poulenc Rorer Sa New taxoids, their preparation and the pharmaceutical compositions containing them.
FR2711369B1 (en) * 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa New taxoids, their preparation and the compositions containing them.
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
ES2151277T3 (en) * 1996-05-22 2000-12-16 Protarga Inc COMPOSITIONS INCLUDING CONJUGATES OF CIS-DOCOSAHEXAENOIC ACID AND TAXOTERE.
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
CA3031283A1 (en) * 2004-01-22 2005-08-04 University Of Miami Topical co-enzyme q10 formulations and methods of use
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
KR20180056816A (en) 2009-05-11 2018-05-29 베르그 엘엘씨 Methods for treatment of disease using an epimetabolic shifter (coenzyme q10)
JP6092844B2 (en) 2011-04-04 2017-03-08 バーグ エルエルシー Treatment of central nervous system tumors
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
NZ713868A (en) 2013-04-08 2021-12-24 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
SG10201907816RA (en) 2013-09-04 2019-09-27 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme q10

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (en) * 1986-07-17 1988-09-23 Rhone Poulenc Sante TAXOL DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
KR950704540A (en) 1995-11-20
MX9306883A (en) 1995-01-31
FI952294A (en) 1995-05-11
RU95112464A (en) 1997-02-20
CZ122495A3 (en) 1995-12-13
WO1994011547A1 (en) 1994-05-26
NO951772D0 (en) 1995-05-05
ZA938366B (en) 1994-06-13
NO951772L (en) 1995-05-05
CA2149240A1 (en) 1994-05-26
AU5425794A (en) 1994-06-08
FI952294A0 (en) 1995-05-11
FR2697841B1 (en) 1995-01-13
FR2697841A1 (en) 1994-05-13
PL308957A1 (en) 1995-09-04
EP0667922A1 (en) 1995-08-23
JPH08503261A (en) 1996-04-09

Similar Documents

Publication Publication Date Title
SK60895A3 (en) Taxane derivatives and process for their preparation
HUT56565A (en) Process for producing 3-arylcarbonyl-1h-indole derivatives and pharmaceutical compositions comprising same
IL121465A0 (en) 2-thiohydantoin derivatives and process for their preparation
HU9400478D0 (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
GB2240104B (en) New arylvinylamide derivatives and process for their preparation
GB9116896D0 (en) 3-deoxymannosamine derivatives and process for their preparation
GB9120628D0 (en) Pyrrolobenzoxazine derivatives and process for preparation thereof
HU9802965D0 (en) Iminothiazolidine intermediers and process for their preparation
ZA933899B (en) Thienothiazine derivatives process for their preparation and their use
GB9204945D0 (en) 3-aryl-glycidic ester derivatives and process for their preparation
HUT66140A (en) New 2-spirocyclopropyl-cephalosporin-sulfone derivatives and process for the preparation thereof
CS199791A3 (en) Aminodiole derivatives and process for preparing thereof
ZA911927B (en) Labdanes and process for their preparation
OA09959A (en) Process for preparing 3-acylestratrienes and acylbenzenes
HU9400404D0 (en) Substituted imidazo-benzoxazin-1-one derivatives and process for producing them
HUT63629A (en) Process for producing substituted phenylquinazoline derivatives and pharmaceutical compositions comprising same
IL116968A0 (en) Ethyl 6-trichloroacetimidoxy-4-hexenoate and the process for the preparation thereof
ZA9335B (en) Difluoromethylenandrostenone derivatives and process for their preparation
HU9203899D0 (en) Method for producing spiro-oxindole derivatives and pharmaceutical preparatives containing them
HU9301501D0 (en) Methods for producing pyrido-benzo-indole derivatives and pharmaceutical preparatives containing them
EP0562231A3 (en) Esters, process for their preparation and use
GB9201286D0 (en) 3-methyleneandrostane derivatives and process for their preparation
GB9224188D0 (en) Imidazolyalkyl-imidazolidinone derivatives and process for their preparation
GB9127401D0 (en) Arylidene-homophthalimide derivatives and process for their preparation
GB9216770D0 (en) (2h-pyrrol-2-ylidene)methyl derivatives and process for their preparation